Low RASSF6 expression in pancreatic ductal adenocarcinoma is associated with poor survival

Figure 3 Survival curves of patients with pancreatic ductal adenocarcinoma in regards to RASSF6 expression. A: There was a significant correlation between RASSF6 expression levels and overall survival (P = 0.009); B: Overall survival of patients with strongly positive RASSF6 staining was significantly higher than overall survival of those whose tumor was negative (P = 0.006); C: Weakly positive staining vs negative staining (P = 0.047); D: Overall survival of patients with positive RASSF6 staining (strongly positive plus weakly positive staining) remained better than survival of patients with negative staining of RASSF6 (P = 0.004).